Brief: Lansen Pharmaceutical Sees Net Profit For Year To Decrease By 99%
Jan 26 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* FY NET PROFIT IS EXPECTED TO RECORD A SIGNIFICANT DECREASE
OF
APPROXIMATELY 99%
* FOR YEAR, GROUP'S REVENUE IS EXPECTED TO BE ABOUT SAME AS
LAST
YEAR
* SEES OPERATING PROFIT FOR YEAR EXPECTED TO RECORD
SIGNIFICANT
DECREASE OF 38%
* EXPECTED RESULTS OF DECREASE IN REVENUE DUE TO DECREASE IN
SALES
VOLUME AND ADJUSTED SALES STRATEGIES IMPLEMENTED GRADUALLY
Further company coverage: 0503.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year